Experiences with N, N-dimethyl-2-phenylcyclo-propylamine in chronic anergic schizophrenic patients.
D003521:Cyclopropanes / Q000031:analogs & derivatives; D008996:Monoamine Oxidase Inhibitors / Q000628:therapy*; D011437:Propylamines; D012559:Schizophrenia / Q000628:therapy*
D003521:Cyclopropanes; D008996:Monoamine Oxidase Inhibitors; D011437:Propylamines; C030797:cyclopropane
CYCLOPROPANE/related compounds; MONOAMINE OXIDASE INHIBITORS/therapy; SCHIZOPHRENIA/therapy